CTOs on the Move

Tobii Dynavox

www.tobiidynavox.com

 
Tobii Dynavox, a wholly owned subsidiary of Tobii AB (publ), is the leading global provider of eye tracking enabled and touch-based augmented and alternative communication (AAC) devices as well as symbol-based products for individuals with special needs.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

National Seating and Mobility

We`re all about mobility. Our made-just-for-you mobility devices keep you moving through all of life`s challenges. And, as a preferred provider, we`re moving our industry ahead with state-of-the-art technology and uniquely engineered wheelchair components. We build the right chairs for people with severe physical challenges. Many are children with birth defects, such as Cerebral Palsy, Muscular Dystrophy and Spina Bifida. We also serve teens, adults and seniors challenged with severe trauma, disease and skeletal disorders. To get it right, we must continually adhere to a spider web of ever-changing state and federal laws, as well as insurance regulations. This requires a dedicated team of master ATPs, expert compliance /funding specialists and a national management team dedicated to what`s best for our clients. Thanks to our talented hardworking team of people, we`re able to accomplish our mission—one wheelchair at a time.

Argon Medical Devices Inc

Argon Medical Devices, Inc. (Argon), founded in 1972 is a leading manufacturer and supplier of single-use Vascular Access Devices. Argon's products are divided into Cardiology, Radiology and Critical Care product lines. Argon supplies disposable

Lifespan of Battle Creek

Lifespan of Battle Creek is a Battle Creek, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viable Health Group (usa)

Viable Health Group (usa) is a Millbrae, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.